Abiopharma

Alvotech announces planned CEO succession and leadership transition

Alvotech announces planned CEO succession and leadership transition

Alvotech tilkynnir breytingar á yfirstjórn félagsins

Evotec SE (EVOTF) Files Form 6-K

(85% Positive) Alkermes plc. (ALKS) Announces Clinical Development Update

(86% Positive) Fractyl Health, Inc. (GUTS) Announces Clinical Development Update

Cartesian Therapeutics Announces New Employment Inducement Grants

Ionis to present at 44th Annual J.P. Morgan Healthcare Conference

GSK plc (GLAXF) Files Form 6-K

Viridian Therapeutics, Inc. - Viridian Therapeutics Prepares for Transformational 2026

(75% Positive) GENPREX, INC. (GNPX) Announces Clinical Development Update

Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics Prepares for Transformational 2026

Insulet - Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health